Application 040610
- Type
- ANDA
- Sponsor
- VISTAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PHENYTOIN | PHENYTOIN | SUSPENSION;ORAL | 125MG/5ML | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A040610-001 | PHENYTOIN | 125MG/5ML | SUSPENSION / ORAL | AB | 2005-08-18 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A040610-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A040610-001 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A040610-001 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A040610-001 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A040610-001 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A040610-001 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A040610-001 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A040610-001 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A040610-001 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A040610-001 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A040610-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A040610-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenytoin Infatabs | PHENYTOIN | Prasco Laboratories | 3580e6a8-f7c3-44a0-a1eb-2a84ae589d21 | 2026-05-22 | Warnings, Adverse reactions | PHENYTOIN |
| Phenytoin | PHENYTOIN | REMEDYREPACK INC. | 31e8a777-75b1-4f48-9682-0bcc3189ad26 | 2026-05-19 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Dilantin Infatabs | PHENYTOIN | Parke-Davis Div of Pfizer Inc | ca119a89-2394-4d34-8078-cd1fa4e8e2f1 | 2026-05-12 | Warnings, Adverse reactions | PHENYTOIN |
| Phenytoin | PHENYTOIN | Major Pharmaceuticals | 08a9d26b-4419-43ec-98f3-43d4534c2e76 | 2026-04-29 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | Sun Pharmaceutical Industries, Inc. | 78b38e7b-1460-4adc-b738-320ffa6259c2 | 2026-03-27 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | NCS HealthCare of KY, LLC dba Vangard Labs | 98bd1d9f-b1a4-49eb-a0b4-a790265710dd | 2026-02-25 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | American Health Packaging | f9fe4c92-2761-4cb4-9cf3-7066e240e014 | 2025-09-17 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | Sun Pharmaceutical Industries, Inc. | 093fd736-5971-47af-b4ef-08c1696cebe8 | 2025-08-19 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | ATLANTIC BIOLOGICALS CORP. | 09daf485-3355-44cb-92af-072dd281e129 | 2025-05-28 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | Mylan Pharmaceuticals Inc. | 37943ec1-a8d2-42df-967e-6f96f84c017b | 2024-12-24 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | PAI Holdings, LLC dba PAI Pharma | f2c74e35-ed8d-4ea6-b7a5-7be0b0155c15 | 2024-11-19 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin | PHENYTOIN | American Health Packaging | 352007dd-0587-4597-8338-c13eda4c5d63 | 2024-10-03 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Phenytoin Infatabs | PHENYTOIN | NCS HealthCare of KY, LLC dba Vangard Labs | 0d240b2b-bc5c-4989-a20b-54ed37a09a4f | 2024-04-11 | Warnings, Adverse reactions | PHENYTOIN |
| Phenytoin | PHENYTOIN | Rising Pharma Holdings, Inc. | e95cad66-b5f9-4802-a35f-fed340bf09ab | 2024-03-14 | Warnings, Adverse reactions | Phenytoin PHENYTOIN |
| Dilantin-125 | PHENYTOIN | Viatris Specialty LLC | f339f9e4-b289-4efe-82b9-46c57d1dc277 | 2023-02-02 | Warnings, Adverse reactions | PHENYTOIN |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 64950-231 | Phenytoin | Phenytoin | Genus Lifesciences Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 66689-775 | Phenytoin | Phenytoin | VistaPharm, Inc. | ANDA | Current |
| 70518-2554 | Phenytoin | Phenytoin | REMEDYREPACK INC. | ANDA | Current |
| 70518-3353 | Phenytoin | Phenytoin | REMEDYREPACK INC. | ANDA | Current |